10 Stocks to Watch on Friday
It’s a mixed day at the stock market as the investors are trying to anticipate the next policy move by the Federal Reserve.
Biogen Inc. (BIIB)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 1,098,100 | $231,260 | +142% | 0.61% |
| 2. | Renaissance Technologies Jim Simons | 1,044,207 | $219,910 | -3% | 0.25% |
| 3. | D E Shaw D. E. Shaw | 993,880 | $209,312 | +67% | 0.19% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 988,077 | $208,089 | +3% | 0.25% |
| 5. | Southeastern Asset Management Mason Hawkins | 842,962 | $177,528 | -2% | 3.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $267.00 | 898 | Director | 2,943 | 2021-02-09 | Filing | |
| $241.31 | 3,100 | Officer, Director | 34,810 | 2020-11-30 | Filing | |
| $231.24 | 38,000 | Director | 643,000 | 2019-05-02 | Filing | |
| $229.46 | 30,000 | Director | 605,000 | 2019-05-01 | Filing | |
| $229.25 | 50,342 | Director | 575,000 | 2019-04-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $440.00 | 7,672 | Officer | 10,169 | 2021-06-07 | Filing | |
| $440.00 | 3,087 | Officer | 2,919 | 2021-06-07 | Filing | |
| $274.17 | 360 | Director | 7,400 | 2021-06-04 | Filing | |
| $350.00 | 1,500 | Officer | 13,066 | 2020-11-04 | Filing | |
| $295.29 | 270 | Director | 15,438 | 2020-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,163,312 | $244,993,507 | 0.1% | |
| 2. | 170,517 | $35,910,880 | 0.04% | |
| 3. | 935 | $19,691,100 | 0.02% | |
| 4. | 50,900 | $10,719,540 | 0.08% | |
| 5. | 47,459 | $9,994,865 | 0.12% |
News See All
10 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at ten biotechnology stocks to buy according to billionaire DE Shaw.
5 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management
In this piece we will take a look at the top five healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management. If you want to learn about Mr.
10 Biotech Stocks Hedge Funds Are Talking About
In this article, we present the list of the 10 biotech stocks hedge funds are talking about.
10 Large-Cap Stocks Hedge Funds Are Talking About
In this article, we will share the insights on 10 large-cap stocks hedge funds are talking about.
Is Biogen (BIIB) A Great Long-Term Buy?
Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its “Longleaf Partners Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded ...
5 Stocks Making Headlines Following Earnings Reports
In this article, we discuss the 5 stocks making headlines following earnings reports.
10 Biotech Stocks to Buy According to Matthew Strobeck’s Birchview Capital
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Were Hedge Funds Right About Biogen Inc. (BIIB)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Here is What Hedge Funds Think About Biogen Inc. (BIIB)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Billionaire Hedge Funds
